Skip To Main Content
Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Audience metrics
  • Listenership
    1K-10K monthly listeners
  • Reviews
    4.1 (30 ratings)
Chart positions
Podcast details
  • Network
  • Language
    English
  • Genre
    Health & Fitness, Fitness
  • Location
    Cleveland
People

Contact

Contact information
Website
https://my.clevelandclinic.org/departments/heart
Social Media

Recent episodes

  • Oct 01, 2026 — Milind Desai, MD, and Per Wierup, MD, discuss the evaluation and management of high-risk aortic valve endocarditis, including indications for urgent intervention and timing of surgery. They also review operative approaches to patients with heart...

    No transcript available.

    Management of Complex Aortic Valve Endocarditis
  • Sep 24, 2026 — Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phospholipids and lipoprotein(a). They discuss the potential mechanisms linking lipoprotein(a) to cardiovascular...

    No transcript available.

    Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk
  • Sep 17, 2026 — In this excerpt from Tall Rounds®, Gianluca Torregrossa, MD, discusses minimally invasive and totally endoscopic coronary artery bypass grafting (TECAB), highlighting procedural advances that enable multi-vessel revascularization through less invasive...

    No transcript available.

    Talking Tall Rounds®: Updates on Less Invasive Cardiac Surgery
  • Sep 10, 2026 — Steven Nissen, MD, and Luke Laffin, MD, discuss one-year follow-up data for CTX310, a CRISPR-Cas9 gene-editing therapy targeting ANGPTL3 to treat lipid disorders. They review the sustained reductions in LDL cholesterol and triglycerides, and the...

    CTX310 and the Future of Gene Editing for Lipid Disorders
  • Sep 03, 2026 — Steven Nissen, MD, and Ashish Sarraju, MD, discuss early clinical data on Kylo-11, a novel therapy that produced substantial reductions in lipoprotein(a) for up to one year after a single injection. Lowering lipoprotein(a), a genetically determined...

    Evaluating Kylo-11 for Long-Acting Lipoprotein(a) Suppression

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals Journalists